Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.38 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.34 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.34 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.34 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.34 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.34 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.34 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25883261 | 0.85 | NR3C2 (0.39) | SMN1; SMN2ALDH1A1DPP4DPP7 | |
| SCHEMBL25883463 | 0.81 | KDM4E (0.38) | KDM4ESMN1; SMN2ALDH1A1CACNA1BDPP4 | |
| SCHEMBL25882920 | 0.80 | SIGMAR1 (0.33) | KDM4ESMN1; SMN2ALDH1A1CACNA1BDPP4 | |
| SCHEMBL21911488 | 0.80 | SIGMAR1 (0.48) | KDM4ECACNA1BSIGMAR1SLC6A9 | |
| SCHEMBL25881984 | 0.79 | SIGMAR1 (0.40) | SMN1; SMN2ALDH1A1DPP4DPP7DPP8 | |
| SCHEMBL25882229 | 0.79 | SIGMAR1 (0.40) | SMN1; SMN2ALDH1A1DPP4DPP7DPP8 | |
| SCHEMBL25881977 | 0.79 | SIGMAR1 (0.40) | SMN1; SMN2ALDH1A1DPP4DPP7DPP8 | |
| SCHEMBL25882219 | 0.79 | SIGMAR1 (0.40) | SMN1; SMN2ALDH1A1DPP4DPP7DPP8 | |
| SCHEMBL25882915 | 0.79 | KMT2A (0.36) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL25883264 | 0.76 | SIGMAR1 (0.39) | SMN1; SMN2ALDH1A1CACNA1BSIGMAR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713316-B2 | Substituted naphthyridinone compounds useful as T cell activators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713316-B2 | Substituted naphthyridinone compounds useful as T cell activators | DGKZ, DGKA, DGKG | KDM4E 1982/4885SMN1; SMN2 4357/4885ALDH1A1 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.